Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

BANNER HEALTH

Parent11 subsidiariesUEI: JVERHVTFJLH1CAGE: 4LZF7

BANNER HEALTH is a federal contractor, registered under UEI JVERHVTFJLH1 and CAGE code 4LZF7. It has been awarded $77,304,080 across 807 federal contracts. Primary work spans Unknown NAICS and Other NAICS codes (2 codes, <0.5% each). Top awarding agencies include Department Of Health And Human Services, Department Of Health And Human Services (hhs), and Other agencies (1 agencies, <0.5% each).

Contact Information

Registration and classification details

Registration

UEI Code

JVERHVTFJLH1

CAGE Code

4LZF7

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Non-Profit Organization

NAICS Codes

621112Offices of Physicians, Mental Health Specialists(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Banner Health provides specialized laboratory and biological manufacturing services primarily to federal health agencies, with a focus on research-support infrastructure and precision bioscience supply chains. Their core capabilities include the production and handling of biological research materia...

Banner Health provides specialized laboratory and biological manufacturing services primarily to federal health agencies, with a focus on research-support infrastructure and precision bioscience supply chains. Their core capabilities include the production and handling of biological research materials, such as human brain tissue samples, and the coordination of complex research operations through dedicated scientific personnel. They demonstrate technical expertise in biospecimen procurement, cold-chain logistics for neural tissue, and compliance with ethical and regulatory standards for human-derived research materials. Their work as a research coordinator suggests strong operational capabilities in managing multi-site studies, data integrity protocols, and interagency scientific collaboration. Key differentiators include hands-on experience with neurobiological specimens and end-to-end support for NIH-funded research initiatives, positioning them as a trusted provider of high-integrity biological resources for sensitive neurological studies. Banner Health’s primary federal partner is the Department of Health and Human Services, where they deliver mission-critical laboratory supplies and research coordination services. Their engagements reflect a pattern of sustained, project-based support for National Institutes of Health components, particularly those focused on neurological and biomedical research. This long-standing relationship indicates familiarity with HHS grant management frameworks, IRB compliance, and the operational rhythms of federally funded scientific programs. Their industry focus centers on biological product manufacturing and testing laboratory services, translating into the end-to-end handling of human-derived research materials and analytical support for neuroscientific inquiry. They occupy a niche within the biomedical research ecosystem, serving as a bridge between academic institutions and federal research programs requiring ethically sourced, high-purity biological specimens. Banner Health is a nonprofit healthcare system headquartered in Phoenix, Arizona, structured as an 8H entity under federal contracting rules. While no formal government certifications are listed, their operational model reflects deep alignment with federal research compliance standards. Their geographic presence in Arizona supports regional access to research networks and biospecimen repositories critical to HHS-funded studies.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Award Analytics & Distribution

Awards by Agency
Department Of Health And Human Services$74.1M95.9%
Department Of Health And Human Services (hhs)$3.2M4.1%
Other agencies (1 agencies, <0.5% each)$47.8K0.1%
Awards by NAICS
Export
- Unknown NAICS$77.3M100%
Others - Other NAICS codes (2 codes, <0.5% each)$22.9K0%
Awards by Agency Over Time
Awards by Place of Performance

Compete with BANNER HEALTH

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for BANNER HEALTH

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS

Open opportunities in BANNER HEALTH's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The National Institutes of Health (NIH) funding opportunity PA-27-102 supports U.S. small business concerns (SBCs) in performing research and development to create commercial products that enhance health, lengthen life, and reduce illness and disability. A mandatory requirement for this Small Business Technology Transfer (STTR) program is a formal collaboration with a non-profit research institution. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the research toward commercialization. Eligible applicants include for-profit entities located in the U.S. with no more than 500 employees, which must be more than 50 percent owned and controlled by U.S. citizens or permanent resident aliens. The opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with budget limits varying by institute, typically ranging from 400,000 to 700,000 dollars for Phase I and up to 3,000,000 dollars for Phase II. Applications are evaluated based on scientific and technical merit through a peer review system, resulting in an overall impact score. Key evaluation criteria include commercial potential, the quality of the commercialization plan, and, for clinical trials, the scientific rationale and regulatory plan. While clinical trials are generally permitted, they are not accepted by specific components such as NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. Recipients must adhere to strict administrative requirements, including maintaining active SAM and UEI registrations, implementing cybersecurity incident reporting procedures with a 48-hour notification window, and registering applicable clinical trials on ClinicalTrials.gov. Submissions must be made via Grants.gov and tracked through eRA Commons, with a response deadline of April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products that support the missions of these agencies. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility and Phase II advancing the research toward commercialization. Eligible applicants include for-profit U.S. businesses with fewer than 500 employees. The opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications. Funding levels vary by participating institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Awards are based on scientific and technical merit, fund availability, and relevance to program goals, with a heavy emphasis on significance, environment, and commercial potential. While clinical trials are generally permitted, certain institutes, including the FDA components and NCATS, do not accept them under this specific notice. Applicants must maintain active SAM registration and a Unique Entity Identifier. Special requirements include a 48-hour cybersecurity incident reporting window and mandatory registration of applicable clinical trials on ClinicalTrials.gov. Applications must be submitted electronically via ASSIST, Grants.gov Workspace, or an institutional system-to-system solution by the deadline of April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The Commercialization Readiness Pilot (CRP) program, under solicitation PAR-27-098, provides later-stage research and development and technical assistance to small business concerns that have previously received an NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough award. The program is designed to bridge the gap between late-stage development and full commercialization by supporting activities such as clinical trials, IND or IDE-enabling studies, manufacturing scale-up, regulatory strategy, and intellectual property planning. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in the oversight and management of the project. The maximum project period is three years, and funding levels vary by NIH institute, ranging from 500,000 to 2,000,000 dollars. Eligible applicants must maintain active registrations in the System for Award Management and the SBA Company Registry. Applications are evaluated based on scientific and technical merit through a peer review system, with a focus on the project's likelihood to exert a powerful influence on the relevant market. Certain NIH components, including the NHLBI, NIAID, and NCATS, among others, do not accept clinical trials under this specific funding opportunity. Prohibited costs include patent or FDA filing fees and separate Technical and Business Assistance funding. All applications must be submitted electronically by the specified deadlines, with the program expiring on April 6, 2029.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 7 months
View Details